MedPath

C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks

Completed
Conditions
Hereditary Angioedema
Interventions
Drug: rhC1INH or pdC1INH
Registration Number
NCT01397864
Lead Sponsor
Pharming Technologies B.V.
Brief Summary

This is a non-interventional treatment Registry of Hereditary Angioedema (HAE) patients treated with C1 inhibitor, either plasma-derived (pdC1INH) or the recombinant human form (rhC1INH / Ruconest), to observe adverse events and insufficient efficacy, and to assess the immunological profile following single and repeated treatment with Ruconest.

Detailed Description

see below

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
181
Inclusion Criteria
  • Decision to treat the HAE patient with C1 inhibitor (either Ruconest or pdC1INH)
  • Patients must give written informed consent
Exclusion Criteria
  • A diagnosis of acquired C1INH deficiency (AAE)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Hereditary AngioedemarhC1INH or pdC1INH-
Primary Outcome Measures
NameTimeMethod
The primary objective is to observe the adverse event profile and insufficient efficacy, following single and repeated treatment with Ruconest or pdC1INH of acute angioedema attacksDecember 2019
Secondary Outcome Measures
NameTimeMethod
To assess the immunological profile of Ruconest (for suspected hypersensitivity or suspected neutralizing antibodies)December 2019

Trial Locations

Locations (17)

UMHAT Alexandrovska EAD

🇧🇬

Sofia, Bulgaria

KBC Split

🇭🇷

Split, Croatia

CHC Sestre milosrdnice

🇭🇷

Zagreb, Croatia

General Hospital Sibenik

🇭🇷

Šibenik, Croatia

Faculty Hospital by St. Anna Brno

🇨🇿

Brno, Czech Republic

Hospital A Michallon, CHU Grenoble

🇫🇷

La Tronche, France

Charite Universitatsmedizin Berlin

🇩🇪

Berlin, Germany

Semmelweis University, 3rd Department of Internal Medicine

🇭🇺

Budapest, Hungary

Ospedale Luigi Sacco

🇮🇹

Milan, Italy

PHI University Clinic of Dermatology

🇲🇰

Skopje, Macedonia, The Former Yugoslav Republic of

Scroll for more (7 remaining)
UMHAT Alexandrovska EAD
🇧🇬Sofia, Bulgaria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.